GB201908155D0 - Leader sequence - Google Patents

Leader sequence

Info

Publication number
GB201908155D0
GB201908155D0 GBGB1908155.3A GB201908155A GB201908155D0 GB 201908155 D0 GB201908155 D0 GB 201908155D0 GB 201908155 A GB201908155 A GB 201908155A GB 201908155 D0 GB201908155 D0 GB 201908155D0
Authority
GB
United Kingdom
Prior art keywords
leader sequence
leader
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1908155.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Warwick
Original Assignee
University of Warwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Warwick filed Critical University of Warwick
Priority to GBGB1908155.3A priority Critical patent/GB201908155D0/en
Publication of GB201908155D0 publication Critical patent/GB201908155D0/en
Priority to MX2021015121A priority patent/MX2021015121A/es
Priority to AU2020288380A priority patent/AU2020288380A1/en
Priority to PCT/GB2020/051380 priority patent/WO2020245611A1/en
Priority to SG11202113297RA priority patent/SG11202113297RA/en
Priority to BR112021024592A priority patent/BR112021024592A2/pt
Priority to US17/613,911 priority patent/US20230076614A1/en
Priority to CN202080042046.3A priority patent/CN114008205A/zh
Priority to JP2021572387A priority patent/JP7748288B2/ja
Priority to CA3142462A priority patent/CA3142462A1/en
Priority to EP20732657.0A priority patent/EP3980545A1/en
Priority to KR1020217042571A priority patent/KR20220133757A/ko
Priority to JP2025064761A priority patent/JP2025114573A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GBGB1908155.3A 2019-06-07 2019-06-07 Leader sequence Ceased GB201908155D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1908155.3A GB201908155D0 (en) 2019-06-07 2019-06-07 Leader sequence
KR1020217042571A KR20220133757A (ko) 2019-06-07 2020-06-05 리더 서열
US17/613,911 US20230076614A1 (en) 2019-06-07 2020-06-05 Leader sequence
AU2020288380A AU2020288380A1 (en) 2019-06-07 2020-06-05 Leader sequence
PCT/GB2020/051380 WO2020245611A1 (en) 2019-06-07 2020-06-05 Leader sequence
SG11202113297RA SG11202113297RA (en) 2019-06-07 2020-06-05 Leader sequence
BR112021024592A BR112021024592A2 (pt) 2019-06-07 2020-06-05 Sequência líder
MX2021015121A MX2021015121A (es) 2019-06-07 2020-06-05 Secuencias lider.
CN202080042046.3A CN114008205A (zh) 2019-06-07 2020-06-05 前导序列
JP2021572387A JP7748288B2 (ja) 2019-06-07 2020-06-05 リーダー配列
CA3142462A CA3142462A1 (en) 2019-06-07 2020-06-05 Leader sequence
EP20732657.0A EP3980545A1 (en) 2019-06-07 2020-06-05 Leader sequence
JP2025064761A JP2025114573A (ja) 2019-06-07 2025-04-10 リーダー配列

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1908155.3A GB201908155D0 (en) 2019-06-07 2019-06-07 Leader sequence

Publications (1)

Publication Number Publication Date
GB201908155D0 true GB201908155D0 (en) 2019-07-24

Family

ID=67386182

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1908155.3A Ceased GB201908155D0 (en) 2019-06-07 2019-06-07 Leader sequence

Country Status (12)

Country Link
US (1) US20230076614A1 (enExample)
EP (1) EP3980545A1 (enExample)
JP (2) JP7748288B2 (enExample)
KR (1) KR20220133757A (enExample)
CN (1) CN114008205A (enExample)
AU (1) AU2020288380A1 (enExample)
BR (1) BR112021024592A2 (enExample)
CA (1) CA3142462A1 (enExample)
GB (1) GB201908155D0 (enExample)
MX (1) MX2021015121A (enExample)
SG (1) SG11202113297RA (enExample)
WO (1) WO2020245611A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4479082A2 (en) * 2022-02-15 2024-12-25 The Broad Institute, Inc. Cell-type specific targeting contractile injection system
EP4547848A1 (en) 2022-06-30 2025-05-07 Københavns Universitet Contractile injection system and use thereof
CN119735656A (zh) * 2023-09-22 2025-04-01 北京朝赛蕴生物科技有限公司 一种蛋白复合物的制备纯化及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
WO2014138324A1 (en) * 2013-03-07 2014-09-12 The General Hospital Corporation Compositions and methods for bacterial delivery of polypeptides
MA42987A (fr) * 2015-10-14 2021-06-02 BASF Agricultural Solutions Seed US LLC Gène axmi554 de l'endotoxine delta et ses procédés d'utilisation

Also Published As

Publication number Publication date
US20230076614A1 (en) 2023-03-09
BR112021024592A2 (pt) 2022-01-18
CN114008205A (zh) 2022-02-01
JP2022535283A (ja) 2022-08-05
KR20220133757A (ko) 2022-10-05
CA3142462A1 (en) 2020-12-10
WO2020245611A1 (en) 2020-12-10
EP3980545A1 (en) 2022-04-13
AU2020288380A1 (en) 2022-01-06
SG11202113297RA (en) 2021-12-30
JP7748288B2 (ja) 2025-10-02
JP2025114573A (ja) 2025-08-05
MX2021015121A (es) 2022-03-17

Similar Documents

Publication Publication Date Title
CA194148S (en) Camera
CA190078S (en) Case
CA200452S (en) Camera
ZAA201801355S (en) Case
ZAA201801144S (en) Case
LT3810587T (lt) Pakeisti alkoksipiridinilo indolsulfonamidai
CA186861S (en) Camera
CA196077S (en) Camera
CA189867S (en) Camera
CA208387S (en) Camera
SG11202113297RA (en) Leader sequence
CA193344S (en) Camera
SMT202300247T1 (it) Inibitori della secrezione proteica a base di triazaciclododecansulfonamide ("tcd")
CA189432S (en) Case
CA189431S (en) Case
PH32018000823S1 (en) Case
PH32018000821S1 (en) Case
PH32018000819S1 (en) Case
PH32018000816S1 (en) Case

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)